Facet Biotech

The Fastest Growing Sector In Healthcare | Monday, September 06th, 2010
Monoclonal antibodies could boost your portfolio.

Abbott abandons plans to sell vaccines business | Sunday, September 05th, 2010
WASHINGTON (AP) - Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies. North Chicago-based Abbott acquired the unit as part of its $6.2 billion purchase of Belgium-based Solvay Pharmaceuticals in February. "We ...

Abbott abandons plans to sell vaccines business | Saturday, September 04th, 2010
Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies. North Chicago-based Abbott acquired the unit as part of its $6.

Abbott Laboratories to retain vaccines business after shopping unit to rivals | Friday, September 03rd, 2010
WASHINGTON - Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months

Abbott abandons plans to sell vaccines business | Friday, September 03rd, 2010
Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies. North Chicago-based Abbott acquired the unit as part of its $6.2 billion... Abbott Laboratories - Business - Chicago - Medical device - Company

The Fastest Growing Sector In Healthcare - Motley Fool UK | Monday, September 06th, 2010
Abbot Labs bought mAbs developer Facet Biotech for $450m. As the drug list above indicates, Roche is the industry leader. This is mainly due to Roche buying out the remaining 44% (that it didn't own) of Genentech for ...

Abbott will keep vaccines business - Batavia Sun | Saturday, September 04th, 2010
and Facet Biotech Corp. Shares of Abbott Laboratories Inc. closed up 13 cents Friday to $50.74.

Abbott abandons plans to sell vaccines business - AP - msnbc.com | Friday, September 03rd, 2010
and Facet Biotech Corp. Shares of Abbott Laboratories Inc. fell 11 cents Friday to $50.72 in afternoon trading.

Abbott Laboratories to retain vaccines business after shopping unit to rivals - Washington Examiner | Friday, September 03rd, 2010
and Facet Biotech Corp. Shares of Abbott Laboratories Inc. fell 8 cents Friday to $50.53 in afternoon trading. It's been that long? Fox News Channel's Geraldo Rivera celebrates his 40th year in the broadcast news ...

PHARMA: Abbott abandons plans to sell vaccines business - North County Times | Friday, September 03rd, 2010
and Facet Biotech Corp.

Global - Drug Design - An Important Aspect Of The R&D Process - PipelineReview.com (press release) | Monday, September 06th, 2010


Global - Drug Design - An Important Aspect Of The R&D Process PipelineReview.com (press release) BMI View: The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development ...

Abbott: Discards plans to sell vaccine business - Healthcare Digital (press release) | Monday, September 06th, 2010


Abbott: Discards plans to sell vaccine business Healthcare Digital (press release) ... acquisitions have encompassed contact lens solution maker Advanced Medical Optics; Evalve, a maker of heart repair equipment; and Facet Biotech Corp. and more »

The Fastest Growing Sector In Healthcare - Motley Fool UK | Monday, September 06th, 2010


The Fastest Growing Sector In Healthcare Motley Fool UK Bristol Myers Squibb bought Medarex for $2.4bn in 2009 and, in a recent deal, Abbot Labs bought mAbs developer Facet Biotech for $450m. ...

Twice the learning - Pune Newsline | Sunday, September 05th, 2010


Twice the learning Pune Newsline When one sits down to write about the impact a teacher has in the life of a student, a new facet can be uncovered every time. ... and more »

Abbott abandons plans to sell vaccines business - Baxter Bulletin | Saturday, September 04th, 2010


Abbott abandons plans to sell vaccines business Baxter Bulletin ... acquisitions have included contact lens solution maker Advanced Medical Optics; Evalve, a maker of heart repair equipment; and Facet Biotech Corp. and more »

Costco Locations: Costco Hours 2010: Costco Coupons Sale Retail ... | Monday, September 06th, 2010
Abbott Laboratories Buys Facet Biotech Corp Acquisition Sold Corporation Deal Cost Price Stock Latest News updates Pictures Videos Photos Wiki Images YouTube - Reports have indicated that Abbott Laboratories, a Drug and medical products ...

Abbott Completes Acquisition of Facet Biotech: April 21, 2010 | Wednesday, April 21st, 2010
The final step in the acquisition process was a short-form merger of Amber Acquisition Inc., a wholly-owned subsidiary of Abbott, with and into Facet Biotech Corporation. As a result of the merger, all outstanding shares of Facet common ...

Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies ... | Thursday, March 11th, 2010
Facet Biotech had to put up with some patronizing, rather snippy statements from Biogen Idec during an attempted hostile takeover last fall. HereR.

The Facet Biotech Buyout Saga (FACT, BIIB, ABT, PDLI) : BioHealth ... | Wednesday, March 10th, 2010
Facet Biotech Corporation (NASDAQ: FACT) is a buyout saga that seemed as though it would never end in 2009. The company is now finally being acquired, but not by Biogen Idec (NASDAQ: BIIB). Abbott Laboratories (NYSE: ABT) announced last ...

Stocks in the News: Facet Biotech, InterMune, American Eagle ... | Wednesday, March 10th, 2010
The following is a round-up of news likely to affect stock prices today: Facet Biotech (FACT) shares soared over 67% in premarket trading after it agreed to be acquired by Abbott Laboratories (ABT) for $722 million, or $27 a share.

Facet Biotech - Homepage | 
Abbott completed its acquisition of Facet Biotech on April 21, 2010. ... © copyright 2010 Facet Biotech Corporation. All rights reserved. Terms of Use ...

Facet Biotech - Contact | 
Contact. We are committed to uncovering new scientific insights in oncology and immunology. Facet Biotech ... © copyright 2010 Facet Biotech Corporation. All rights reserved. Terms ...

Facet Biotech News - FierceBiotech | 
Read the latest Facet Biotech news and developments from FierceBiotech. Also, feel free to sign up for the Facet Biotech news RSS feed.

facet biotech | Biotech and Biotechnology News | BIO | TheStreet | 
Stay informed on the latest facet biotech news. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.

Abbott Laboratories to Buy Facet Biotech for $722 Million ... | 
Facet Biotech is a biotechnology company dedicated to advancing its ... Facet Biotech has development collaborations with Biogen Idec, Bristol-Myers ...

Related post in blog - facet biotech:

Facet Biotech - Homepage - Monday, September 06th, 2010
Innovation begins with imagination. Welcome to Facet Biotech..

Facet Biotech - Pipeline - Monday, September 06th, 2010
We are applying our unique biological insights to improve patients' lives.

Symbol Lookup from Yahoo! Finance - Sunday, September 05th, 2010
Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance..

Facet Biotech Corporation: Information from Answers.com - Friday, August 06th, 2010
Facet Biotech Corporation Contact Information Facet Biotech Corporation 1400 Seaport Blvd. Redwood City, CA 94063 CA Tel.

FACET BIOTECH Stock Analysis: Facet Biotech - A Rewarding Spinoff - Thursday, September 02nd, 2010
Facet Biotech - A Rewarding Spinoff | Posted by WDiJohns on 02/07/2009. UpDown.com stock analysis: FACET BIOTECH (FACT).

Warning: MagpieRSS: Failed to fetch http://digg.com/rss_search?s=facet+biotech (HTTP Response: ) in /home/bejogat/public_html/buzzntrends.com/rss_fetch.inc on line 238
Related post in Digg - facet biotech:

Warning: array_slice() expects parameter 1 to be array, null given in /home/bejogat/public_html/buzzntrends.com/trendinfo.php on line 440

Warning: Invalid argument supplied for foreach() in /home/bejogat/public_html/buzzntrends.com/trendinfo.php on line 441

Related post in Delicious - facet biotech:

UPDATE 3-Abbott to buy Facet for $27/shr, topping Biogen bid | Reuters - Wednesday, March 10th, 2010
Abbott to buy Facet for $27/shr, topping Biogen bid.

Related post in Yahoo Answers - facet biotech: